CANNON GILLIAN sold 45.0% of their position (1.19K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $63.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/9/2026ACC: 0001193125-26-262671
-1.19K
Net shares
Net seller
$63.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.19K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−1.19K
Price / share
$53.14
Trade value
$63.24K
% of position
45.0%
6/5/2026
2.65K→1.46K
Total
Net shares
−1.19K
Net value
-$63.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/5/2026 | S · Sale | −1.19K | $53.14 | $63.24K | 45.0% | 2.65K | 1.46K |
| Total | −1.19K | -$63.24K | ||||||
Derivative Transactions0
No derivative transactions reported